BlackRock’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-13,348,066
Closed -$223M 5799
2022
Q4
$223M Buy
13,348,066
+280,906
+2% +$4.75M 0.01% 1448
2022
Q3
$224M Sell
13,067,160
-1,779,219
-12% -$27.9M 0.01% 1384
2022
Q2
$116M Buy
14,846,379
+3,721,861
+33% +$32M ﹤0.01% 1917
2022
Q1
$123M Buy
11,124,518
+1,052,260
+10% +$11.8M ﹤0.01% 2007
2021
Q4
$177M Buy
10,072,258
+913,044
+10% +$17.7M ﹤0.01% 1831
2021
Q3
$185M Buy
9,159,214
+587,477
+7% +$15.1M 0.01% 1774
2021
Q2
$283M Buy
8,571,737
+2,030,196
+31% +$76.6M 0.01% 1513
2021
Q1
$256M Buy
6,541,541
+477,435
+8% +$22.4M 0.01% 1549
2020
Q4
$265M Buy
6,064,106
+58,758
+1% +$2.01M 0.01% 1398
2020
Q3
$170M Buy
6,005,348
+4,455,397
+287% +$141M 0.01% 1510
2020
Q2
$56.3M Buy
1,549,951
+369,307
+31% +$10.4M ﹤0.01% 2181
2020
Q1
$21.4M Buy
+1,180,644
New +$25.9M ﹤0.01% 2569

BlackRock's ONEM Position: Q1 2023 in Review

BlackRock sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 13,348,066 shares — an estimated $223M sold.

BlackRock first reported a position in ONEM in Q1 2020 and held it in 12 quarters. The position peaked at $283M in Q2 2021. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • BlackRock reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • BlackRock sold 13,348,066 1Life Healthcare shares in Q1 2023, an estimated $223M.
  • BlackRock first reported a position in 1Life Healthcare in Q1 2020 and held it in 12 quarters.
  • BlackRock's 1Life Healthcare position peaked at $283M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on BlackRock's 13F filing for Q1 2023, filed 12 May 2023.